Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.04.21 | Ernst Russ - Specialising in shipping business | 738 | Edison Investment Research | Ernst Russ (ERAG) continues to build its position in the maritime business with the acquisition of two ships in December 2020 and another two in February 2021. As a result, it now owns a majority interest... ► Artikel lesen | |
07.04.21 | AAC Clyde Space - Building the platforms for growth | 418 | Edison Investment Research | AAC Clyde Space has agreed the proposed acquisition of Swedish scientific instrument maker Omnisys Instruments for an initial consideration of c SEK75m in a cash and equity deal. It has also undertaken... ► Artikel lesen | |
07.04.21 | Hepion Pharmaceuticals - Phase IIa readout upcoming | 414 | Edison Investment Research | Despite a challenging operating environment due to COVID-19, Hepion was able to advance its CRV431 development program (for the treatment of non-alcoholic steatohepatitis, NASH) without major disruption... ► Artikel lesen | |
07.04.21 | Mondo TV - The deals keep coming | 359 | Edison Investment Research | Mondo TV produced good FY20 results, with production value up by 14% to €30.4m and an uptick in EBITDA margin (on production value) from 61.4% to 61.8%. The strengthening of the balance sheet through... ► Artikel lesen | |
07.04.21 | Claranova - Profitable growth in H121 | 299 | Edison Investment Research | Claranova made good progress in H121, with organic constant currency revenue growth of 17% y-o-y and EBITDA growth of 106% y-o-y. Recent acquisitions made by PlanetArt are progressing well and the division... ► Artikel lesen | |
07.04.21 | Newron Pharmaceuticals - Gate not yet open to Phase III | 370 | Edison Investment Research | Newron is developing evenamide as an add-on to existing anti-psychotic therapies to treat poorly managed and refractory schizophrenia. Two recently completed safety studies, one in patients and the... ► Artikel lesen | |
07.04.21 | Norcros - Momentum maintained | 316 | Edison Investment Research | Following the latest trading update, we have increased our earnings estimates again. Trading momentum is expected to continue beyond the year end and we now expect dividends to normalise more quickly.... ► Artikel lesen | |
07.04.21 | Pharnext - Pivotal Phase III initiated | 401 | Edison Investment Research | Pharnext announced on 31 March 2021 that it has enrolled its first patient in the pivotal Phase III study of PTX3003 for the treatment of Charcot-Marie-Tooth Disease (CMT) type Ia (the PREMIER study).... ► Artikel lesen | |
07.04.21 | Pixium Vision - Back to basics as Second Sight deal is called off | 559 | Edison Investment Research | Pixium announced on 3 April that it had been notified by Second Sight of its unilateral decision to terminate the January 2021 memorandum of understanding (MOU) relating to the proposed business combination... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 7.409 |
TESLA | 3.664 |
NVIDIA | 1.952 |
TUI | 1.524 |
NEL | 1.383 |
SUPER MICRO COMPUTER | 1.304 |
VARTA | 1.169 |
META PLATFORMS | 1.123 |
RHEINMETALL | 1.084 |
BAYER | 1.076 |
INFINEON | 1.052 |
DEUTSCHE BANK | 1.032 |
AIXTRON SE | 959 |
RENK GROUP | 914 |
BYD | 777 |
PLUG POWER | 765 |
BASF | 713 |
COMMERZBANK | 646 |
DEUTSCHE LUFTHANSA | 594 |
RWE | 579 |
THYSSENKRUPP | 529 |
ALLIANZ | 514 |
MERCEDES-BENZ | 502 |
VOLKSWAGEN | 467 |
DEUTSCHE TELEKOM | 446 |